Case number 2015-2067
Eli Lilly and Company v. Teva Parenteral Medicines > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ELI LILLY AND COMPANY v. TEVA PARENTERAL MEDICINES [OPINION] [precedential] (0) |
| Feb 21, 2017 | 71 | Mandate issued to the United States District Court for the Southern District of Indiana. Service as of this date by Clerk of Court. [408956] [CAB] [Entered: 02/21/2017 09:38 AM] (1) |
| Jan 12, 2017 | 70 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Prost,Chief Judge; Newman,Circuit Judge and Dyk,Circuit Judge). [398095] [CAB] [Entered: 01/12/2017 09:17 AM] (35) |
| Sep 7, 2016 | 69 | Submitted after ORAL ARGUMENT by Mr. William M. Jay for Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc., APP Pharmaceuticals LLC, Teva Parenteral Medicines, Inc. and Pliva Hrvatska D.O.O. and Adam Lawrence Perlman for Eli Lilly and Company. Panel: Judge: Prost , Judge: Newman , Judge: Dyk. [364703] [LAJ] [Entered: 09/07/2016 12:47 PM] (0) |
| Aug 11, 2016 | 68 | Response to oral argument order from the Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. designating William M. Jay as arguing attorney. Designated time for argument: 11 minutes. Designated time for rebuttal: 4 minutes. Service of other counsel by Notice of Docket Activity from this entry. [358094] [William Jay] [Entered: 08/11/2016 02:16 PM] (0) |
| Aug 11, 2016 | 67 | Entry of appearance for William M. Jay as of counsel for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 08/11/2016 by email. [358089] [William Jay] [Entered: 08/11/2016 02:05 PM] (1) |
| Jul 21, 2016 | 66 | Response to oral argument order from the Appellee Eli Lilly and Company. designating Adam L. Perlman as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [352634] [Adam Perlman] [Entered: 07/21/2016 01:10 PM] (0) |
| Jul 21, 2016 | 65 | NOTICE OF CALENDARING. Panel: 1609C. Case scheduled Sep 07, 2016 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 08/15/2016. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [352559] THIS NOTICE APPLIES TO CASE(S): [15-1802, 15-1919, 15-2067, 15-5146] [JAB] [Entered: 07/21/2016 11:21 AM] (0) |
| Jul 13, 2016 | 64 | Certificate of Interest for the Amicus Curiae Generic Pharmaceutical Association. Service: 07/13/2016 by email. [350648] [Christina McCullough] [Entered: 07/13/2016 08:14 PM] (2) |
| Jul 13, 2016 | 63 | Notice to counsel for Amicus Curiae Generic Pharmaceutical Association: The record of this case indicates that the Certificate of Interest has not been filed. A completed certificate of Interest must be submitted in accordance with Fed. Cir. R. 47.4 by 07/14/2016. Service as of this date by Clerk of Court. [350479] [CAB] [Entered: 07/13/2016 12:08 PM] (0) |
| Jun 22, 2016 | 62 | 6 paper copies of the Amicus Brief [60] received from Amicus Curiae Biotechnology Innovation Organization. [345842] [KW] [Entered: 06/22/2016 03:36 PM] (0) |
| Jun 21, 2016 | 61 | Certificate of Interest for the Amicus Curiae Biotechnology Innovation Organization. Service: 06/21/2016 by email. [345418] [Hansjorg Sauer] [Entered: 06/21/2016 02:11 PM] (3) |
| Jun 20, 2016 | 60 | AMICUS BRIEF FILED for Biotechnology Innovation Organization [42]. Number of Pages: 15. Service: 03/11/2015 by email. Pursuant to Fed. Cir. R. 29(a), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 06/27/2016. [345087] [CAB] [Entered: 06/20/2016 03:48 PM] (23) |
| Jun 20, 2016 | 59 | ORDER filed. The motion [39] is granted. The Biotechnology Innovation Organization's amicus brief is accepted for filing. Service: 06/20/2016 by clerk. [345045] [LMS] [Entered: 06/20/2016 03:02 PM] (2) |
| Apr 8, 2016 | 58 | 6 paper copies of the Joint Appendix (Vol. I - II) [57] received from Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. [325424] [MJL] [Entered: 04/11/2016 03:39 PM] (0) |
| Apr 1, 2016 | 57 | JOINT APPENDIX, VOLS. 1 - 2 FILED for APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc. [56]. Number of Pages: 1071. Service: 04/01/2016 by email. Pursuant to Fed. Cir. R. 30(a)(5), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/11/2016. [324220] [CAB] [Entered: 04/05/2016 04:23 PM] (1071) |
| Apr 1, 2016 | 56 | TENDERED from Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Title: JOINT APPENDIX. Service: 04/01/2016 by email. [323429] [Michael Cottler] [Entered: 04/01/2016 05:32 PM] (1071) |
| Mar 30, 2016 | 55 | 7 paper copies of the Reply Brief [54] received from Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. [322897] [LAJ] [Entered: 03/30/2016 03:11 PM] (0) |
| Mar 25, 2016 | 54 | REPLY BRIEF FILED for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc., and Teva Pharmaceuticals USA, Inc. [52]. Number of Pages: 30. Service: 03/25/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/04/2016. Appendix is due 04/04/2016. [322410] [CAB] [Entered: 03/29/2016 11:28 AM] (44) |
| Mar 25, 2016 | 52 | TENDERED from Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Title: REPLY BRIEF. Service: 03/25/2016 by email. [321922] [Daryl Wiesen] [Entered: 03/25/2016 05:41 PM] (44) |
| Mar 22, 2016 | 53 | 6 paper copies of the amicus Brief [50] received from Amicus Curiae Pharmaceutical Research and Manufacturers of America. [322125] [LAJ] [Entered: 03/28/2016 02:17 PM] (0) |
| Mar 18, 2016 | 51 | Certificate of Interest for the Amicus Curiae Pharmaceutical Research and Manufacturers of America. Service: 03/18/2016 by email. [320136] [Kevin Prussia] [Entered: 03/18/2016 05:02 PM] (2) |
| Mar 18, 2016 | 50 | AMICUS BRIEF FILED for Pharmaceutical Research and Manufacturers of America [47]. Number of Pages: 30. Service: 03/11/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/23/2016. [320114] [CAB] [Entered: 03/18/2016 04:21 PM] (39) |
| Mar 18, 2016 | 49 | ORDER filed granting motion for leave to file an amicus curiae brief [46]. The Pharmaceutical Research and Manufacturers of America’s amicus brief is accepted for filing. Service: 03/18/2016 by clerk. [319998] [NL] [Entered: 03/18/2016 12:45 PM] (2) |
| Mar 11, 2016 | 47 | TENDERED from Pharmaceutical Research and Manufacturers of America Title: AMICUS CURIAE BRIEF. Service: 03/11/2016 by email. [318078] [Kevin Prussia] [Entered: 03/11/2016 09:21 PM] (39) |
| Mar 11, 2016 | 46 | MOTION of Pharmaceutical Research and Manufacturers of America for leave to file an amicus curiae brief. Response/Opposition is due 03/24/2016 [Consent: partial consent]. Service: 03/11/2016 by email. [318077] [Kevin Prussia] [Entered: 03/11/2016 09:15 PM] (8) |
| Mar 11, 2016 | 45 | Entry of appearance for Sameer Ahmed as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/11/2016 by email. [318073] [Sameer Ahmed] [Entered: 03/11/2016 05:57 PM] (2) |
| Mar 11, 2016 | 44 | Entry of appearance for Jamie T. Wisz as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/11/2016 by email. [318072] [Jamie Wisz] [Entered: 03/11/2016 05:53 PM] (2) |
| Mar 11, 2016 | 43 | Entry of appearance for Kevin S. Prussia as principal counsel for Pharmaceutical Research and Manufacturers of America. Service: 03/11/2016 by email. [318070] [Kevin Prussia] [Entered: 03/11/2016 05:39 PM] (2) |
| Mar 11, 2016 | 42 | TENDERED from Biotechnology Innovation Organization Title: AMICUS CURIAE BRIEF. Service: 03/11/2016 by email. [318067] [Hansjorg Sauer] [Entered: 03/11/2016 05:06 PM] (23) |
| Mar 11, 2016 | 41 | Entry of appearance for Hans Sauer as of counsel for Biotechnology Innovation Organization. Service: 03/11/2016 by email. [318066] [Hansjorg Sauer] [Entered: 03/11/2016 05:04 PM] (3) |
| Mar 11, 2016 | 40 | Entry of appearance for David S. Forman as principal counsel for Biotechnology Innovation Organization. Service: 03/11/2016 by email. [318065] [Hansjorg Sauer] [Entered: 03/11/2016 05:02 PM] (3) |
| Mar 11, 2016 | 39 | MOTION of Biotechnology Innovation Organization for leave to file an amicus curiae brief. Response/Opposition is due 03/26/2015 [Consent: partial consent]. Service: 03/11/2015 by email. [318063] [Hansjorg Sauer] [Entered: 03/11/2016 05:00 PM] (7) |
| Mar 10, 2016 | 48 | 6 paper copies of the Opening Response Brief [36] received from Appellee Eli Lilly and Company. [318346] [LAJ] [Entered: 03/14/2016 02:19 PM] (0) |
| Mar 10, 2016 | 38 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [37] filed by Appellants Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc., APP Pharmaceuticals LLC, Teva Parenteral Medicines, Inc., and Pliva Hrvatska D.O.O. Reply brief is due 03/25/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [317530] [CAB] [Entered: 03/10/2016 01:40 PM] (0) |
| Mar 9, 2016 | 37 | MOTION of Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc. to extend the time to 03/25/2016 at 11:59 pm to file the reply brief. Response/Opposition is due 03/24/2016 [Consent: unopposed]. Service: 03/09/2016 by email. [317307] [Daryl Wiesen] [Entered: 03/09/2016 06:04 PM] (7) |
| Mar 4, 2016 | 36 | BRIEF FILED for Appellee Eli Lilly and Company [35]. Number of Pages: 64. Service: 03/04/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/14/2016. [316287] [CAB] [Entered: 03/07/2016 12:49 PM] (74) |
| Mar 4, 2016 | 35 | TENDERED from Appellee Eli Lilly and Company. Title: RESPONSE BRIEF. Service: 03/04/2016 by email. [316119] [Adam Perlman] [Entered: 03/04/2016 06:19 PM] (74) |
| Jan 19, 2016 | 34 | 6 paper copies of the Amicus Brief [33] received from Amicus Curiae Generic Pharmaceutical Association. [303759] [MJL] [Entered: 01/19/2016 09:30 AM] (0) |
| Jan 15, 2016 | 33 | AMICUS BRIEF FILED for Generic Pharmaceutical Association [31]. Number of Pages: 20. Service: 01/06/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 01/20/2016. [303461] [CAB] [Entered: 01/15/2016 02:10 PM] (27) |
| Jan 15, 2016 | 32 | ORDER filed granting motion for leave to file an amicus curiae brief [30] filed by Amicus Curiae Generic Pharmaceutical Association. The Generic Pharmaceutical Associations amicus brief is accepted for filing. Service: by. [303376] [NL] [Entered: 01/15/2016 12:20 PM] (2) |
| Jan 6, 2016 | 31 | TENDERED from Amicus Curiae Generic Pharmaceutical Association. Title: AMICUS CURIAE BRIEF. Service: 01/06/2016 by email. [300759] [Christina McCullough] [Entered: 01/06/2016 12:46 PM] (27) |
| Jan 6, 2016 | 30 | MOTION of Amicus Curiae Generic Pharmaceutical Association for leave to file an amicus curiae brief. Response/Opposition is due 01/23/2015 [Consent: partial consent]. Service: 01/07/2015 by email. [300756] [Christina McCullough] [Entered: 01/06/2016 12:44 PM] (6) |
| Dec 30, 2015 | 29 | 6 paper copies of the Opening Brief [28] received from Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. [299584] [MJL] [Entered: 12/31/2015 08:53 AM] (0) |
| Dec 23, 2015 | 28 | BRIEF FILED for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc. [27]. Number of Pages: 63. Service: 12/23/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 01/04/2016. [299243] [FMS] [Entered: 12/29/2015 03:02 PM] (160) |
| Dec 23, 2015 | 27 | TENDERED from Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Title: OPENING BRIEF. Service: 12/23/2015 by email. [298679] [Daryl Wiesen] [Entered: 12/23/2015 05:42 PM] (160) |
| Dec 22, 2015 | 26 | Entry of appearance for Henry C. Dinger as of counsel for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 12/22/2015 by email. [298249] [Henry Dinger] [Entered: 12/22/2015 03:35 PM] (2) |
| Dec 10, 2015 | 25 | **TEXT ONLY** ORDER granting motion to extend time to file amicus brief [24] amicus brief due 01/06/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [295022] [JW] [Entered: 12/10/2015 09:22 AM] (0) |
| Dec 9, 2015 | 24 | MOTION of Generic Pharmaceutical Association to extend the time to 01/06/2016 to file the amicus curiae brief. Response/Opposition is due 12/28/2015 [Consent: unopposed]. Service: 12/09/2015 by email. [294966] [Christina McCullough] [Entered: 12/09/2015 07:16 PM] (3) |
| Dec 9, 2015 | 23 | Entry of appearance for Shannon M. Bloodworth as of counsel for Generic Pharmaceutical Association. Service: 12/09/2015 by email. [294963] [Shannon Bloodworth] [Entered: 12/09/2015 06:36 PM] (2) |
| Dec 9, 2015 | 22 | Entry of appearance for Christina J. McCullough as principal counsel for Generic Pharmaceutical Association. Service: 12/09/2015 by email. [294962] [Christina McCullough] [Entered: 12/09/2015 06:31 PM] (2) |
| Nov 5, 2015 | 21 | ORDER granting motion to set briefing schedule [20] filed by Appellants Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc., APP Pharmaceuticals LLC, Teva Parenteral Medicines, Inc., Pliva Hrvatska D.O.O. and Appellee Eli Lilly and Company. Appellants' opening brief is due no later than 12/23/2015. Appellee’s response brief is due no later than 03/04/2016. Appellants’ reply brief is due no later than 03/18/2016. Service: 11/05/2015 by clerk. [286626] [NL] [Entered: 11/05/2015 03:13 PM] (2) |
| Nov 2, 2015 | 20 | MOTION of Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc., Teva Pharmaceuticals USA, Inc. and Appellee Eli Lilly and Company to set briefing schedule. Response/Opposition is due 11/16/2015 [Consent: unopposed]. Service: 11/02/2015 by email, fax. [285187] [Daryl Wiesen] [Entered: 11/02/2015 12:38 PM] (12) |
| Oct 9, 2015 | 19 | Transcript Purchase Order Form for the Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc. indicating that a transcript is already on file. Service: 10/09/2015 by email. [279495] [Daryl Wiesen] [Entered: 10/09/2015 05:18 PM] (2) |
| Oct 9, 2015 | 18 | Certificate of Interest for the Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 10/09/2015 by email. [279494] [Daryl Wiesen] [Entered: 10/09/2015 05:17 PM] (2) |
| Oct 9, 2015 | 17 | Docketing Statement for the Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 10/09/2015 by email. [279493] [Daryl Wiesen] [Entered: 10/09/2015 05:16 PM] (4) |
| Oct 9, 2015 | 16 | Entry of appearance for Natasha E. Daughtrey as of counsel for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 10/09/2015 by email. [279491] [Natasha Daughtrey] [Entered: 10/09/2015 05:14 PM] (2) |
| Oct 9, 2015 | 15 | Entry of appearance for Brian J. Prew as of counsel for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 10/09/2015 by email. [279487] [Brian Prew] [Entered: 10/09/2015 05:11 PM] (2) |
| Oct 9, 2015 | 14 | Entry of appearance for Elaine Herrmann Blais as of counsel for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 10/09/2015 by email. [279484] [Elaine Blais] [Entered: 10/09/2015 05:06 PM] (2) |
| Oct 9, 2015 | 13 | Entry of appearance for Michael B. Cottler as of counsel for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 10/09/2015 by email. [279483] [Michael Cottler] [Entered: 10/09/2015 05:04 PM] (2) |
| Oct 9, 2015 | 12 | Entry of appearance for Emily L. Rapalino as of counsel for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 10/09/2015 by email. [279479] [Emily Rapalino] [Entered: 10/09/2015 05:01 PM] (2) |
| Oct 9, 2015 | 11 | Entry of appearance for Elaine Harrmann Blais as of counsel for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 10/09/2015 by email. [279469] [Elaine Blais] [Entered: 10/09/2015 04:58 PM] (2) |
| Oct 9, 2015 | 10 | Entry of appearance for Daryl L. Wiesen as principal counsel for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 10/09/2015 by email. [279462] [Daryl Wiesen] [Entered: 10/09/2015 04:54 PM] (2) |
| Oct 9, 2015 | 9 | Docketing Statement for the Appellee Eli Lilly and Company. Service: 10/09/2015 by email. [279437] [Allison Rushing] [Entered: 10/09/2015 04:29 PM] (3) |
| Oct 9, 2015 | 8 | Certificate of Interest for the Appellee Eli Lilly and Company. Service: 10/09/2015 by email. [279436] [Allison Rushing] [Entered: 10/09/2015 04:28 PM] (3) |
| Oct 9, 2015 | 7 | Entry of appearance for Allison B. Jones as of counsel for Appellee Eli Lilly and Company. Service: 10/09/2015 by email. [279435] [Allison Rushing] [Entered: 10/09/2015 04:27 PM] (2) |
| Oct 9, 2015 | 6 | Entry of appearance for David M. Krinsky as of counsel for Appellee Eli Lilly and Company. Service: 10/09/2015 by email. [279433] [Allison Rushing] [Entered: 10/09/2015 04:26 PM] (2) |
| Oct 9, 2015 | 5 | Entry of appearance for Dov P. Grossman as of counsel for Appellee Eli Lilly and Company. Service: 10/09/2015 by email. [279432] [Allison Rushing] [Entered: 10/09/2015 04:25 PM] (2) |
| Oct 9, 2015 | 4 | Entry of appearance for Ellen E. Oberwetter as of counsel for Appellee Eli Lilly and Company. Service: 10/09/2015 by email. [279431] [Allison Rushing] [Entered: 10/09/2015 04:23 PM] (2) |
| Oct 9, 2015 | 3 | Entry of appearance for Bruce R. Genderson as of counsel for Appellee Eli Lilly and Company. Service: 10/09/2015 by email. [279430] [Allison Rushing] [Entered: 10/09/2015 04:22 PM] (2) |
| Oct 9, 2015 | 2 | Entry of appearance for Adam L. Perlman as principal counsel for Appellee Eli Lilly and Company. Service: 10/09/2015 by email. [279427] [Allison Rushing] [Entered: 10/09/2015 04:20 PM] (2) |
| Sep 25, 2015 | 1 | Appeal docketed. Received: 09/22/2015. [275100]Entry of Appearance due 10/09/2015. Certificate of Interest is due on 10/09/2015. Docketing Statement due 10/09/2015. Appellant/Petitioner's brief is due 11/24/2015. [SJ] [Entered: 09/25/2015 08:43 AM] (140) |
